Business, energy, technology, markets and global industry news from Business News Today

biotech M&A

PharmaDeviceNews biotech M&A
Representative image of proteomics data analysis as Seer’s takeover pressure puts diagnostics platforms, biomarker discovery and life sciences technology value in focus.
Medical Devices & Diagnostics

Why the Radoff-JEC bid for Seer is bigger than a small-cap biotech takeover fight

Find out why Seer’s activist battle could reshape investor thinking on proteomics, diagnostics platforms and biotech value creation.

Read More
Pharma & Biotech

Neurocrine’s $2.9bn Soleno deal raises the stakes in Prader-Willi syndrome treatment

Find out how Neurocrine’s $2.9bn Soleno acquisition could reshape VYKAT XR’s rare disease launch strategy.

Read More
Representative image: Scientists review DNA delivery and lipid nanoparticle research in a genetic medicines lab as Eli Lilly’s Engage Bio acquisition highlights the growing race to solve non-viral drug delivery challenges.
Pharma & Biotech

Eli Lilly expands genetic medicines toolkit with Engage Bio’s non-viral DNA delivery system

Eli Lilly’s Engage Bio deal is small by its standards, but DNA delivery may become a big battleground in genetic medicines.

Read More
Pharma & Biotech

XenoTherapeutics’ takeover of Repare wins near-unanimous vote: What’s at stake for the pipeline

Repare shareholders approve XenoTherapeutics deal. Find out how this nonprofit acquisition could reshape oncology pipeline models.

Read More